INDIA
MARKET LENS
MARKETS INSIGHTS
Headlines
Markets
Company Analysis
Editor's Corner
Newsroom
▾
📰
Front page
Today's lead and the desks
🗄️
Archive
Browse every clustered story
Tools
▾
Analyse
🧪
Quant Desk
Regime, herding, factors, pairs
📊
Analytics Lab
36 metrics + Monte Carlo risk
🧮
Analyst Lab
Option Greeks, G-Sec yield, XIRR
⚡
Portfolio Lab
Optimal weights and frontier
Follow the money
🏦
FII & DII Flows
Who bought, who sold, the streaks
👤
Promoter Moves
Stakes, pledges, open offers
💼
Mutual Funds
Returns, categories, new launches
Reference
⚖️
Rules & Regulation
SEBI, exchange and tax changes
🔎
Research Hub
Search the wire and BSE filings
Go
☁ Sync
☰
Go
☁ Sync
📰
Today's report
What happened and why it matters
📈
Markets
Boards, movers and screeners
📰
Newsroom
Specialist desks reading the tape
🗄️
Archive
Browse every clustered story
🔎
Company Analysis
Full research on any tracked stock
✍️
Editor's Corner
Comment and critical analysis
🧪
Quant Desk
Regime, herding, factors, pairs
📊
Analytics Lab
36 metrics + Monte Carlo risk
🧮
Analyst Lab
Option Greeks, G-Sec yield, XIRR
⚡
Portfolio Lab
Optimal weights and frontier
🏦
FII & DII Flows
Who bought, who sold, the streaks
👤
Promoter Moves
Stakes, pledges, open offers
💼
Mutual Funds
Returns, categories, new launches
⚖️
Rules & Regulation
SEBI, exchange and tax changes
🔎
Research Hub
Search the wire and BSE filings
🔍
About
What this platform is, and is not
✉️
Contact
Questions, corrections, feedback
Loading market data
Home
/
Newsroom
/
Alkem launches anti-seizure medication - NeuCeno in India
Alkem launches anti-seizure medication - NeuCeno in India | India Market Lens Newsroom